+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Psychiatric Drugs Explained. Edition No. 6

  • ID: 3688031
  • Book
  • April 2016
  • 360 Pages
  • Elsevier Health Science
1 of 3

Now in its sixth edition, and written by an author internationally recognised in his field, Psychiatric Drugs Explained offers a wealth of information in a handy easy-to-use format. Organised by disorder, and providing a comprehensive review of drug effects, action and side-effects, this fully updated new edition covers the latest drugs on the market, and explores changes in prescribing practice.

The author's approach is distinctive and reader-friendly, to help guide mental health professionals through the benefits and impacts of psychotropic drugs. Additional topics include management of disorders including stimulants and drugs for children, cognitive impairment and sleep disorders.

Note: Product cover images may vary from those shown
2 of 3
Treatment

Section 1 Management of the psychoses

2 The antipsychotics

3 Antipsychotic side effects and their management

References

Section 2 Management of depression

4 The antidepressants

5 Side effects of antidepressants

References

Section 3 Management of bipolar disorders

6 Management of acute bipolar disorder

7 Mood-stabilisers

References

Section 4 Stimulants & Drugs for children

8 Stimulants & Drugs for children

References

Section 5 Management of anxiety

8 The anxiety disorders

10 Benzodiazepine anxiolytics

11 Anxiolysis and the serotonin system

12 Beta-blockers and anxiety

References

Section 6 Management of sleep disorders and insomnia

13 Sleep disorders and insomnia

14 Non-pharmacological management of insomnia

15 Hypnotics

16 Sedatives

References

Section 7 Management of cognitive impairment

17 Cognitive enhancement and the dementias

18 Cognitive enhancement and neuroprotection

References

Section 8 Management of sexual difficulties

19 The range of sexual difficulties

20 Effects of drugs on aspects of sexual functioning

Appendix 20.1 Male sexual functioning questionnaire

Appendix 20.2 Female sexual functioning questionnaire

References

Section 9 Management of dependence and withdrawal

21 Dependence & Withdrawal

22 Dependence & Craving

23 Dependence & Protracted Withdrawal

References

Section 10 Consent, abuse and liability

24 Consent

25 Pharmacological abuse

References

Section 11 The marketing of tranquillity

26 The ethical industry

27 Evidence-biased care

28 Marketing & Risk

29 From healthcare to pharmageddon
Note: Product cover images may vary from those shown
3 of 3
Healy, David Director, North Wales Department of Psychological Medicine, College of Medicine, Cardiff University, Bangor, UK.

A professor of Psychiatry in Wales, David studied medicine in Dublin, and at Cambridge University. He is a former Secretary of the British Association for Psychopharmacology, and has authored more than 200 peer-reviewed articles, 200 other pieces, and 20 books, including The Antidepressant Era and The Creation of Psychopharmacology from Harvard University Press, The Psychopharmacologists Volumes 1-3 and Let Them Eat Prozac from New York University Press, and Mania from Johns Hopkins University Press.

David's latest book, Pharmageddon, documents the riveting and terrifying story of how pharmaceutical companies have hijacked healthcare in America and the life-threatening results.

David's main areas of research are clinical trials in psychopharmacology, the history of psychopharmacology, and the impact of both trials and psychotropic drugs on our culture.
Note: Product cover images may vary from those shown
Adroll
adroll